FDA Update

This presentation will provide an overview of ongoing activities at the U.S. Food and Drug Administration (FDA) regarding tattoo inks and pigments, and the implications of The Modernization of Cosmetic Regulations Act of 2022 (MoCRA). Included in the MoCRA provisions are facility registration and product listing, mandatory recall authority, and mandatory reporting of serious adverse events — all of which have implications for the tattoo industry. This presentation will provide an overview of cosmetics regulations including the major provisions of MoCRA and examples of ongoing work that supports the mission of the FDA to protect public health. It will address the safety of tattoo inks and permanent makeup that have continued to increase in popularity over the past several decades, both in the United States and globally, focusing on ongoing research activities.

MODERATOR

• John Misock, Senior Regulatory Consultant, Ceutical Labs, Inc.

Speaker

• Linda M. Katz, M.D., M.P.H. Director, Office of Cosmetics and Colors, U.S. Food and Drug Administration